RxDoctor Payments Data

Mehrunnisa Sultana, MD

Psychiatry · West Palm Beach, FLNPI 1235205410

Payments from drug & device makers

$9,931in general payments, 2019–2025

Across 581 payments — averaging $17.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Alkermes, Inc.$1K
  • Otsuka America Pharmaceutical, Inc.$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Johnson & Johnson$927
  • plus $3K from 13 others

What the payments were for

  • Food & beverage$9,76498%
  • Education$1672%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,931 in reported general payments places this provider in the 85th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Medicare billing

Part B allowed, 2024
$36,919
Medicare patients
77
Services billed
338

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega TrinzaPaliperidone Palmitate84$727,782
AustedoDeutetrabenazine96$721,828
Invega SustennaPaliperidone Palmitate233$651,296
Austedo XrDeutetrabenazine36$321,109
AristadaAripiprazole Lauroxil77$285,683
VraylarCariprazine Hcl136$231,383
Abilify AsimtufiiAripiprazole25$143,159
Abilify MaintenaAripiprazole45$129,878
Lurasidone Hcl208$63,476
Aripiprazole208$14,689
Haloperidol Decanoate183$8,859
Clozapine133$7,694
Paliperidone ErPaliperidone52$6,221
Bupropion XlBupropion Hcl292$5,995
Divalproex Sodium ErDivalproex Sodium78$4,941

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Trinza, Invega Sustenna$927$1,379,078317 claims
Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr$1,072$1,042,938132 claims
Alkermes, Inc.Aristada$1,283$285,68377 claims
Otsuka America Pharmaceutical, Inc.Abilify Asimtufii, Abilify Maintena$1,099$273,03770 claims
AbbVieVraylar$1,974$231,383136 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in West Palm Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →